QR code

Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage

IntroductionImmunoglobulin replacement therapy (IgRT), either intravenous (IVIg) or subcutaneous (SCIg), is crucial for managing primary immune deficiencies (PIDs) with hypogammaglobulinemia by reducing infection rates and mortality. During the COVID-19 pandemic, a global shortage of SCIg prompted o...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Pedro Moral Moral, Marta Dafne Cabanero-Navalon, Paula Teresa López-León, Héctor Balastegui-Martín, Sandra Martínez Mercader, Amparo Mir, Victor Garcia-Bustos
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2025-01-01
Reeks:Frontiers in Immunology
Onderwerpen:
immunoglobulin replacement therapy
humoral primary immune deficiencies
subcutaneous immunoglobulin
infections
cost-effectiveness
resource shortage
Online toegang:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1527514/full
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items